trending Market Intelligence /marketintelligence/en/news-insights/trending/8k9EclHboE3R6OkYpp7e7A2 content esgSubNav
In This List

Anavex Life Sciences: Appeal in Cortina lawsuit dismissed

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Anavex Life Sciences: Appeal in Cortina lawsuit dismissed

Anavex Life Sciences Corp. said the appeal in Cortina v. Anavex Life Sciences Corp. was dismissed.

No fees or costs were incurred by the company, and the matter had come to a full and final conclusion.

The lawsuit was filed by Kevin Cortina in the U.S. District Court for the Southern District of New York, claiming that the biopharmaceutical company had made materially false and misleading statements regarding its business, operational and compliance policies.